These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 15814246)
21. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics. Derakhshandeh K; Erfan M; Dadashzadeh S Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678 [TBL] [Abstract][Full Text] [Related]
22. Polyethylenglycol-co-poly-D,L-lactide copolymer based microspheres: preparation, characterization and delivery of a model protein. Dorati R; Genta I; Tomasi C; Modena T; Colonna C; Pavanetto F; Perugini P; Conti B J Microencapsul; 2008 Aug; 25(5):330-8. PubMed ID: 18465305 [TBL] [Abstract][Full Text] [Related]
23. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method. Katas H; Chen S; Osamuyimen AA; Cevher E; Oya Alpar H J Microencapsul; 2008 Dec; 25(8):541-8. PubMed ID: 18465303 [TBL] [Abstract][Full Text] [Related]
24. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
25. Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activity. Vargas A; Lange N; Arvinte T; Cerny R; Gurny R; Delie F J Drug Target; 2009 Sep; 17(8):599-609. PubMed ID: 19591536 [TBL] [Abstract][Full Text] [Related]
26. Poly(D,L-lactide-co-glycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency. Gvili K; Benny O; Danino D; Machluf M Biopolymers; 2007 Apr 5-15; 85(5-6):379-91. PubMed ID: 17266128 [TBL] [Abstract][Full Text] [Related]
27. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles. Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055 [TBL] [Abstract][Full Text] [Related]
28. Experimental design and multivariate analysis for optimizing poly(D,L-lactide-co-glycolide) (PLGA) nanoparticle synthesis using molecular micelles. Ganea GM; Sabliov CM; Ishola AO; Fakayode SO; Warner IM J Nanosci Nanotechnol; 2008 Jan; 8(1):280-92. PubMed ID: 18468072 [TBL] [Abstract][Full Text] [Related]
29. Loading efficiency and surface conductance of heparin-modified poly(lactide-co-glycolide) nanoparticles. Kuo YC; Shih KH Colloids Surf B Biointerfaces; 2009 Jul; 71(2):282-7. PubMed ID: 19329287 [TBL] [Abstract][Full Text] [Related]
30. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir. Duvvuri S; Janoria KG; Mitra AK J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919 [TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers. Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965 [TBL] [Abstract][Full Text] [Related]
33. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma. Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660 [TBL] [Abstract][Full Text] [Related]
34. Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Liang HF; Chen CT; Chen SC; Kulkarni AR; Chiu YL; Chen MC; Sung HW Biomaterials; 2006 Mar; 27(9):2051-9. PubMed ID: 16307794 [TBL] [Abstract][Full Text] [Related]
35. Polymeric nanospheres as strategy to increase the amount of triclosan retained in the skin: passive diffusion vs. iontophoresis. Rodríguez-Cruz IM; Merino V; Merino M; Díez O; Nácher A; Quintanar-Guerrero D J Microencapsul; 2013; 30(1):72-80. PubMed ID: 22746545 [TBL] [Abstract][Full Text] [Related]
36. Loading efficiency of stavudine on polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate copolymer nanoparticles. Kuo YC Int J Pharm; 2005 Feb; 290(1-2):161-72. PubMed ID: 15664142 [TBL] [Abstract][Full Text] [Related]
37. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Galindo-Rodriguez S; Allémann E; Fessi H; Doelker E Pharm Res; 2004 Aug; 21(8):1428-39. PubMed ID: 15359578 [TBL] [Abstract][Full Text] [Related]
38. Design and Evaluation of pH-Dependent Nanosystems Based on Cellulose Acetate Phthalate, Nanoparticles Loaded with Chlorhexidine for Periodontal Treatment. Vidal-Romero G; Zambrano-Zaragoza ML; Martínez-Acevedo L; Leyva-Gómez G; Mendoza-Elvira SE; Quintanar-Guerrero D Pharmaceutics; 2019 Nov; 11(11):. PubMed ID: 31766136 [TBL] [Abstract][Full Text] [Related]
39. Local drug delivery systems for the treatment of periodontal disease. Higashi K; Matsushita M; Morisaki K; Hayashi S; Mayumi T J Pharmacobiodyn; 1991 Feb; 14(2):72-81. PubMed ID: 1870076 [TBL] [Abstract][Full Text] [Related]
40. Microbicidal Polymer Nanoparticles Containing Clotrimazole for Treatment of Vulvovaginal Candidiasis. Del Rocío Lara-Sánchez M; Ganem-Rondero A; Nava-Arzaluz MG; Becerril-Osnaya AA; Pérez-Carranza LA; Alcalá-Alcalá S; Mendoza-Muñoz N; Piñón-Segundo E AAPS PharmSciTech; 2024 Aug; 25(7):197. PubMed ID: 39174702 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]